|  |  | Mean | SD | P for ANOVA | P for ANCOVA | P for trend |
---|---|---|---|---|---|---|---|
Boys, N = 121 | Change in TBLH BMC (g) | ||||||
 | IGF-I Q1 | 396 | 112 | < 0.001 | 0.005a | 0.002a | |
 | IGF-I Q2 | 502 | 144 | ||||
 | IGF-I Q3 | 514 | 158 | ||||
 | IGF-I Q4 | 586 | 114 | ||||
Change in TBLH aBMD (g/cm2) | |||||||
 | IGF-I Q1 | 0.098 | 0.041 | < 0.001 | 0.010b | 0.012b | |
 | IGF-I Q2 | 0.138 | 0.062 | ||||
 | IGF-I Q3 | 0.132 | 0.056 | ||||
 | IGF-I Q4 | 0.155 | 0.048 | ||||
Change in TB BMAD (g/cm3) | |||||||
 | IGF-I Q1 | − 0.009 | 0.005 | < 0.001 | nsb | nsb | |
 | IGF-I Q2 | − 0.006 | 0.006 | ||||
 | IGF-I Q3 | − 0.006 | 0.007 | ||||
 | IGF-I Q4 | − 0.002 | 0.007 | ||||
Girls, N = 133 | Change in TBLH BMC (g) | ||||||
 | IGF-I Q1 | 356 | 90 | ns | nsa | nsa | |
 | IGF-I Q2 | 350 | 99 | ||||
 | IGF-I Q3 | 352 | 106 | ||||
 | IGF-I Q4 | 317 | 108 | ||||
Change in TBLH aBMD (g/cm2) | |||||||
 | IGF-I Q1 | 0.093 | 0.043 | ns | nsb | nsb | |
 | IGF-I Q2 | 0.093 | 0.049 | ||||
 | IGF-I Q3 | 0.100 | 0.053 | ||||
 | IGF-I Q4 | 0.096 | 0.046 | ||||
Change in TB BMAD (g/cm3) | |||||||
 | IGF-I Q1 | − 0.007 | 0.006 | < 0.001 | nsb | 0.017b | |
 | IGF-I Q2 | − 0.002 | 0.006 | ||||
 | IGF-I Q3 | 0.000 | 0.006 | ||||
 | IGF-I Q4 | 0.002 | 0.005 |